Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Compound digestive enzyme is a multi-enzyme combination product used to treat digestive disorders and dyspepsia. The formulation typically includes pepsin, pancreatin, cellulase, and diastase, which work synergistically to break down proteins, fats, carbohydrates, and plant fibers in the gastrointestinal tract. This supplementation compensates for endogenous enzyme deficiencies, improving nutrient absorption and relieving symptoms such as bloating, gas, and indigestion. Guangdong Sunho Pharmaceutical produces an approved generic version of this medication in capsule form, which is widely used in the Chinese market for patients with impaired digestive function.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on compound digestive enzyme.